CDKN2A and carcinoma: Mice lacking ARF, but with intact p16INK4a, develop tumours (Kamijo et al, 1997), while transfection of ARF into some carcinoma cell lines results in marked growth inhibition (Simon et al, 1999; Yang et al, 2000).